ScalfariAKnappertzVCutterG, et al. Mortality in patients with multiple sclerosis. Neurology2013; 81(2): 184–192.
2.
ColesA.Physician-assisted death should be available to people with MS. Mult Scler2017; 23(13): 1681.
3.
BueckenRGalushkoMGollaH, et al. Patients feeling severely affected by multiple sclerosis: How do patients want to communicate about end-of-life issues. Patient Educ Couns2012; 88(2): 318–324.
4.
KöpkeSGiordanoAVeroneseS, et al. Patient and caregiver involvement in formulation of guideline questions: Findings from the EAN guideline on palliative care of people with severe multiple sclerosis. Eur J Neurol2019; 26(1): 41–50.
5.
Turner-StokesLSykesNSilberE, et al. Long-term neurological conditions: Management at the interface between neurology, rehabilitation and palliative care. Clin Med2008; 8(2): 186–191.
6.
OliverDJBorasioGDCaraceniA, et al. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease. Eur J Neurol2016; 23(1): 30–38.
7.
Soelberg SorensenPGiovannoniGMontalbanX, et al. The multiple sclerosis care unit. Mult Scler2019; 25: 627–636.
8.
EdmondsPHartSGaoW, et al. Palliative care for people severely affected by multiple sclerosis: Evaluation of a novel palliative care service. Mult Scler2010; 16(5): 627–636.
9.
VeroneseSGalloGValleA, et al. Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: NE-PAL, a pilot randomised controlled study. BMJ Support Palliat Care2017; 7(2): 164–172.
10.
SolariAGiordanoAPattiF, et al. Randomized controlled trial of a home-based palliative approach for people with severe multiple sclerosis. Mult Scler2018; 24(5): 663–674.
